RxDoctor Payments Data

Ashley Holt, PA

Physician Assistant · Rockville, MDNPI 1972815702

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 1,090 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,030in general payments, 2019–2025

Across 1,090 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Novartis$2K
  • Pfizer$963
  • Lundbeck LLC$738
  • UCB, Inc.$710
  • plus $9K from 54 others

What the payments were for

  • Speaking & faculty fees$3752%
  • Food & beverage$18,65598%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)240$3,549
Teva Pharmaceuticals USA, Inc.103$2,438
Novartis150$1,670
Pfizer68$963
Lundbeck LLC36$738
UCB, Inc.30$710
Lilly USA, LLC36$666
Biohaven Pharmaceutical Holding Company Ltd.56$648
EMD Serono, Inc.37$610
Biohaven Pharmaceuticals, Inc.25$603
Biogen25$583
Eisai Inc.28$582
Neurocrine Biosciences, Inc.22$506
Banner Life Sciences, LLC20$309
Bristol Myers Squibb21$286
Sanofi12$254
Upsher-smith Laboratories LLC15$253
Neurelis, Inc.14$249
ANI Pharmaceuticals, Inc.12$248
Acadia Pharmaceuticals Inc9$232
Grifols USA, LLC9$218
Amgen10$199
AstraZeneca(2 entities)8$193
Genentech USA, Inc.7$188
Jazz Pharmaceuticals Inc.6$174
Amneal Pharmaceuticals LLC6$149
Impel Pharmaceuticals LLC5$128
Livanova USA, Inc.7$126
GE HealthCare4$124
Nevro Corp.5$122
Kyowa Kirin, Inc.5$96
Adamas Pharmaceuticals, Inc.5$92
Merz Pharmaceuticals, LLC3$87
Avadel CNS Pharmaceuticals, LLC4$80
Johnson & Johnson(2 entities)3$79
MDD US Operations, LLC3$68
Alnylam Pharmaceuticals Inc.3$65
Impel Pharmaceuticals Inc.3$63
Axsome Therapeutics, Inc.2$50
Avion Pharmaceuticals3$49
Medtronic2$45
Ipsen Biopharmaceuticals, Inc3$45
TG Therapeutics, Inc.1$41
Insightec,inc2$38
Kowa Pharmaceuticals America, Inc.2$35
Sunovion Pharmaceuticals Inc.2$29
Catalyst Pharmaceuticals, Inc.1$27
Cardinal Health 414 LLC1$24
Arbor Pharmaceuticals, Inc.1$23
Supernus Pharmaceuticals, Inc.1$23
Otsuka America Pharmaceutical, Inc.1$23
Sandoz1$23
Tanabe Pharma America, Inc.1$23
Mallinckrodt Hospital Products Inc.1$23
Abbott1$20
CSL Behring1$20
Xeris Pharmaceuticals, Inc.1$19
Springworks Therapeutics, Inc.1$17
Averitas Pharma Inc.1$16
TMS Neurohealth Centers Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,030 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$3,075
Medicare patients
25
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$92,492
Nurtec OdtRimegepant Sulfate30$54,963
RytaryCarbidopa/Levodopa13$20,691
Emgality PenGalcanezumab-Gnlm25$17,453
Rivastigmine24$9,610
Rasagiline Mesylate23$3,825
Entacapone21$3,686
Levetiracetam29$3,000
Carbidopa-Levodopa ErCarbidopa/Levodopa32$2,870
Carbidopa-LevodopaCarbidopa/Levodopa77$2,443
Gabapentin113$2,416
Donepezil Hcl128$1,761
Propranolol Hcl ErPropranolol Hcl25$1,433
Memantine Hcl29$1,320
Pregabalin38$1,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$506$92,49212 claims
PfizerNurtec Odt$963$54,96330 claims
Amneal Pharmaceuticals LLCRytary$149$20,69113 claims
Upsher-smith Laboratories LLCTopiramate$253$31112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →